Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Singapore Institute of Advanced Medicine Holdings Ltd. is extending its strategic partnership with biotech firm EnGeneIC Pty Limited, following promising developments in EnGeneIC’s proprietary technology, the EnGeneIC Dream Vector. The companies have agreed to a 180-day extension to finalize a Definitive Agreement, with EnGeneIC bound by certain exclusivity obligations during this period. This move signifies a deepening of the collaborative efforts in the manufacturing and distribution of EDV-based products and theranostics.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.